These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

278 related items for PubMed ID: 31205194

  • 1. Characteristics of Patients Experiencing Extrapyramidal Symptoms or Other Movement Disorders Related to Dopamine Receptor Blocking Agent Therapy.
    Musco S, Ruekert L, Myers J, Anderson D, Welling M, Cunningham EA.
    J Clin Psychopharmacol; 2019; 39(4):336-343. PubMed ID: 31205194
    [Abstract] [Full Text] [Related]

  • 2. Clinical Spectrum of Drug-Induced Movement Disorders: A Study of 97 Patients.
    Chouksey A, Pandey S.
    Tremor Other Hyperkinet Mov (N Y); 2020 Oct 26; 10():48. PubMed ID: 33178486
    [Abstract] [Full Text] [Related]

  • 3. Setting the record straight: The nosology of tardive syndromes.
    Truong DD, Frei K.
    Parkinsonism Relat Disord; 2019 Feb 26; 59():146-150. PubMed ID: 30528171
    [Abstract] [Full Text] [Related]

  • 4. The nosology of tardive syndromes.
    Frei K, Truong DD, Fahn S, Jankovic J, Hauser RA.
    J Neurol Sci; 2018 Jun 15; 389():10-16. PubMed ID: 29433810
    [Abstract] [Full Text] [Related]

  • 5. Adverse effects of antipsychotic drugs.
    Malhotra AK, Litman RE, Pickar D.
    Drug Saf; 1993 Dec 15; 9(6):429-36. PubMed ID: 7907481
    [Abstract] [Full Text] [Related]

  • 6. Differentiating tardive dyskinesia: a video-based review of antipsychotic-induced movement disorders in clinical practice.
    Hauser RA, Meyer JM, Factor SA, Comella CL, Tanner CM, Xavier RM, Caroff SN, Lundt L.
    CNS Spectr; 2022 Apr 15; 27(2):208-217. PubMed ID: 33213556
    [Abstract] [Full Text] [Related]

  • 7. The Relationship Between Early Haloperidol Response and Associated Extrapyramidal Side Effects.
    Rasmussen SA, Rosebush PI, Mazurek MF.
    J Clin Psychopharmacol; 2017 Feb 15; 37(1):8-12. PubMed ID: 28027109
    [Abstract] [Full Text] [Related]

  • 8. Characteristics of Inpatients Prescribed Dopamine Receptor Blocking Agents.
    Schwartz S, Dinkla L, Pullen J, Bernard R, Kumar A.
    Psychopharmacol Bull; 2021 Nov 03; 51(4):51-64. PubMed ID: 34887599
    [Abstract] [Full Text] [Related]

  • 9. Movement side effects of antipsychotic drugs in adults with and without intellectual disability: UK population-based cohort study.
    Sheehan R, Horsfall L, Strydom A, Osborn D, Walters K, Hassiotis A.
    BMJ Open; 2017 Aug 03; 7(8):e017406. PubMed ID: 28775195
    [Abstract] [Full Text] [Related]

  • 10. The inter-relationships of tardive dyskinesia, parkinsonism, akathisia and tardive dystonia: the Curaçao Extrapyramidal Syndromes Study II.
    van Harten PN, Hoek HW, Matroos GE, Koeter M, Kahn RS.
    Schizophr Res; 1997 Aug 29; 26(2-3):235-42. PubMed ID: 9323356
    [Abstract] [Full Text] [Related]

  • 11. Movement disorders associated with neuroleptic treatment.
    Wirshing WC.
    J Clin Psychiatry; 2001 Aug 29; 62 Suppl 21():15-8. PubMed ID: 11584982
    [Abstract] [Full Text] [Related]

  • 12. Neuroleptic-induced movement disorders: an overview.
    Sachdev PS.
    Psychiatr Clin North Am; 2005 Mar 29; 28(1):255-74, x. PubMed ID: 15733622
    [No Abstract] [Full Text] [Related]

  • 13. The prevalence of metoclopramide-induced tardive dyskinesia and acute extrapyramidal movement disorders.
    Ganzini L, Casey DE, Hoffman WF, McCall AL.
    Arch Intern Med; 1993 Jun 28; 153(12):1469-75. PubMed ID: 8512437
    [Abstract] [Full Text] [Related]

  • 14. Novel antipsychotics, extrapyramidal side effects and tardive dyskinesia.
    Barnes TR, McPhillips MA.
    Int Clin Psychopharmacol; 1998 Mar 28; 13 Suppl 3():S49-57. PubMed ID: 9690971
    [Abstract] [Full Text] [Related]

  • 15. Movement disorders with neuroleptic drug treatment.
    Tarsy D.
    Psychiatr Clin North Am; 1984 Sep 28; 7(3):453-71. PubMed ID: 6148742
    [Abstract] [Full Text] [Related]

  • 16. Treatment of acute neuroleptic-induced movement disorders.
    Tonda ME, Guthrie SK.
    Pharmacotherapy; 1994 Sep 28; 14(5):543-60. PubMed ID: 7997388
    [Abstract] [Full Text] [Related]

  • 17. Clozapine treatment for neuroleptic-induced tardive dyskinesia, parkinsonism, and chronic akathisia in schizophrenic patients.
    Spivak B, Mester R, Abesgaus J, Wittenberg N, Adlersberg S, Gonen N, Weizman A.
    J Clin Psychiatry; 1997 Jul 28; 58(7):318-22. PubMed ID: 9269253
    [Abstract] [Full Text] [Related]

  • 18. Assessment of EPS and tardive dyskinesia in clinical trials. Collaborative Working Group on Clinical Trial Evaluations.
    J Clin Psychiatry; 1998 Jul 28; 59 Suppl 12():23-7. PubMed ID: 9766616
    [Abstract] [Full Text] [Related]

  • 19. The prevalence of tardive dystonia, tardive dyskinesia, parkinsonism and akathisia The Curaçao Extrapyramidal Syndromes Study: I.
    van Harten PN, Matroos GE, Hoek HW, Kahn RS.
    Schizophr Res; 1996 May 28; 19(2-3):195-203. PubMed ID: 8789918
    [Abstract] [Full Text] [Related]

  • 20. Extrapyramidal syndromes in neuroleptic-treated patients: prevalence, risk factors, and association with tardive dyskinesia.
    Muscettola G, Barbato G, Pampallona S, Casiello M, Bollini P.
    J Clin Psychopharmacol; 1999 Jun 28; 19(3):203-8. PubMed ID: 10350026
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 14.